专 论
药动学–药效学模型在新药评价中的应用
庄露凝1, 2, 3,谷 元1, 2,刘昌孝2*
1. 天津大学 化工学院,天津 300072
2. 天津药物研究院 释药技术与药代动力学国家重点实验室,天津 300193 3. 佛罗里达大学 药学院,美国 佛罗里达 32610
摘 要:新药评价已经成为新药研发中最关键的阶段,也是安全合理用药所面临的重大课题。近年来,药动学–药效学(PK/PD)模型受到了越来越广泛的关注,这一模型是将PK和PD两个相互关联的动力学过程有机地结合起来,同时探讨机体对药物的作用及药物对机体的作用,为更全面和准确地了解药物的效应随剂量(或浓度)及时间而变化的规律,从而为临床用药的安全性和有效性提供更为科学的理论依据。着重综述PK/PD模型的发展和在临床前和临床中的应用,证实了PK/PD模型可以为新药评价提供有效的理论指导,并大幅度缩短实验周期,节省实验资源,比传统的药物开发策略更加准确可靠。随着药物评价学的不断完善,模拟软件和模拟条件的标准化,PK/PD模型在未来的药物开发中必将更充分地发挥其重要作用并加速药物开发的进程。
关键词:药动学;药效学;PK/PD模型;药物评价
中图分类号:R969.1 文献标志码:A 文章编号:1674 - 6376 (2011) 03 - 0161 - 06
Application of PK/PD modeling in novel drug evaluation
ZHUANG Lu-ning1, 2, 3, GU Yuan1, 2, LIU Chang-xiao2*
1. College of Chemical Engineering, Tianjin University, Tianjin 300072, China
2. State Key Laboratory of Drug Delivery Technology and Pharmacokinetics, Tianjin Institute of Pharmaceutical Research, Tianjin 300193, China
3. College of Pharmacy, University of Florida, Florida 32610, USA
Abstract: Drug evaluation has become one of the most critical stages during drug development as well as an important tool to assess the efficacy and safety of novel drugs. Pharmacokinetics/pharmacodynamics (PK/PD) modeling, taking both PK and PD process into consideration and thus comprehensively understanding the relationship between dosing (concentration) and time, has drawn more and more attention from the public recently. By investigating the interaction between the drug and the body system, it provides more valuable information for drug application. In this paper, the development history of PK/PD modeling and its application in preclinical and clinical practice will be discussed. It is now proved that the PK/PD modeling can shorten the research cycle, save the experiment resource, and is more accurate and reliable than traditional drug development strategy. With the constant improvement of drug evaluation, the standardization of analytical software, and its simulation process, PK/PD modeling will play more and more important role in drug development and accelerate the overall process.
Key words: pharmacokinetics; pharmacodynamics; pharmacokinetics/pharmacodynamics (PK/PD) modeling; drug evaluation
一般认为药物效应和毒性与血药浓度有直接的关系。但随着药动学(pharmacokinetics,PK)和药效学(pharmacodynamics,PD)的发展,人们发现,血液通常不是药物的直接作用部位,药物作用的直接环境是效应部位(effect site),通常指受体、酶和细胞膜等特异性超微结构。药物从血液运转到效应部位需要一定时间,所以大多数药物效应的变化滞
收稿日期:2011-02-14
基金项目:国家973项目(2010735602)和天津市科技计划项目(08JCYBJC07500) *通讯作者:刘昌孝,研究员,中国工程院院士。E-mail: liuchangxiao@vip.163.com
后于血药浓度的变化。为了更精确地描述药物剂量与药物效应之间的关系,Sheiner[1]在经典药动学中加入效应室,称之为药动学–药效学(PK/PD)模型。该模型在理论研究方面以及一些药物的使用上都有不同程度的应用[2],现已广泛应用于抗心律失常药、镇痛药、降压药、降血糖药以及抗生素类药物等的效应分析。近年来,美国FDA提出在开发治
暂无评价0人阅读0次下载举报文档 药动学-药效学结合模型的研究进展及在新药研发中的应用_建筑/土木_工程科技_专业资料。药动学-药效学结合模型的研究进展及在...
暂无评价0人阅读0次下载举报文档 药动学-药效学结合模型的研究进展及在新药研发中的应用_药学_医药卫生_专业资料。学报 2007 ,38 (6) :481 - 488 Journal...
暂无评价
暂无评价0人阅读0次下载举报文档 药动...药动学- 药效学结合模型的应用进展苏如雄, 林旭文...模型的研究在为各类药物研发中阐明药物作用机制、 ...
暂无评价0人阅读0次下载举报文档 药动学-药效学结合模型的应用进展_交通运输...模型的研究在为各类药物研发中阐明药物作用机制、 能动设计 〔〕1 药物剂型以及...
群体药动学的研究进展及应用【摘要】群体药动学(population pharmacokinetics , ...药动学–药效学模型在新药评价中的 应用[ J]。药物评价研究,2011,34(3):...
暂无评价
热门文档